TB-500 (Thymosin Beta-4) + IGF-1 LR3 Stack

Post-cycle anabolic stack. IGF-1 LR3 drives muscle satellite cell activation while TB-500 handles systemic repair.

The combination of TB-500 (Thymosin Beta-4) and IGF-1 LR3 represents a multi-pathway approach to biological age reduction. By simultaneously targeting distinct hallmarks of aging, this protocol achieves results that exceed the sum of its individual components.

TB-500 (Thymosin Beta-4) primarily acts via upregulates actin to promote cell migration, angiogenesis, and systemic tissue repair., while IGF-1 LR3 complements this by modified igf-1 with an arginine substitution and n-terminal extension that reduces igfbp binding, extending half-life and anabolic activity.. Together, they create a comprehensive cellular environment optimized for longevity and resilience.